Multicenter phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients

Lung Cancer

Volumn 14, Issue 2-3, 1996, Pages 353-360

  Bretti, S ^a   Berruti, A ^b,c   Gorzegno, G ^b,c   La Ciura, P ^d   Paze E ^b,c   Celano, E ^a   Grecchi, G ^d   Perroni, D ^d   Bumma, C ^a   Dogliotti, L ^b,c  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SAN LUIGI GONZAGA HOSPITAL   (Italy)

^d S CROCE E CARLE HOSPITAL   (Italy)

Author keywords

Chemotherapy; Cisplatin; Non small cell lung cancer; Vinorelbine

Indexed keywords

CISPLATIN; NAVELBINE;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG SCREENING; FEMALE; HUMAN; INOPERABLE CANCER; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 0030003232     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-5002(96)00559-4     Document Type: Article

References (15)

1. Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol 1983; 1(11): 710-719.
2. Boring CC, Squires TS, Tong T. Cancer statistics. CA Cancer J Clin 1991; 41: 19-36.
3. Clerici M, Bretti S, Celano A, Panvini D, Comandone A, Casadio C, Luporini G, Bumma C. Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II study. Anticancer Res 1995; 15: 477-478.
4. Depierre R, Lemarie E, Dabouis G, Gamier G, Jacoulet P, Dalphin JC. A phase II study of navelbine (Vinorelbine) in the treatment of non-small cell lung cancer. Am J Clin Oncol 1991; 14: 115-119.
5. Depierre A, Chastang CI, Quoix E, Lebeau B, Blanchon F, Paillot N, Lemarie E, Milleron B, Moro D, Clavier J, Herman D, Tuchais E, Jacoulet P, Brechot JM, Cordier JF, Solal-Celigny P, Badri N, Besenval M. Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial. Ann Oncol 1994; 5: 37-42.
6. Donnadieu N, Paesmans M, Sculier JP. Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literature. Lung Cancer 1991; 7: 243-252.
7. Klastersky J, Sculier JP. Non surgical combined modality therapies in non-small cell lung cancer. Chest 1986; 89 Suppl: 289-294.
8. La Vecchia C, Boyle P, Cislaghi C, Decarli A, Negri E. Descriptive epidemiology of cancer in the upper digestive and respiratory tract in Italy. Rev Epidemiol Santé Publique 1990; 38: 271-273.
9. Le Chevalier T, Brisgand D, Douillard JY, Pujol JL, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Gottfried M, Ruffie P, Panizo A, Gaspard MH, Ravaioli A, Besenval M, Besson F, Martinez A, Berthaud P, Tursz T. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 360-367.
10. Marsoni S, Clerici M. Efficacy, semantic and chemotherapy in advanced NSCLC. Ann Oncol 1994; 5: 303-304.
11. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
12. Rapp E, Pater JL, Willan A et al. Chemotherapy can prolong survival in patients with advanced non small cell lung cancer. Report of a Canadian multicenter randomized trial. J Clin Oncol 1988; 6: 633-641.
13. Sheperd FA. Treatment of advanced non small cell lung cancer. Semin Oncol 1994; 21: 7-18.
14. R. Simon. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989; 10: 1-10.
15. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA. Kaasa S, Pater JL, Quoix E, Rapp E, Tumarello D, Williams J, Woods BL, Bernard JP. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19-21.